Onconova Therapeutics Accounts Payable

Onconova Therapeutics (ONTX) currently reports a accounts payable of $7.7M as of March 2026. Use the charts on this page to explore Onconova Therapeutics's accounts payable history and peer comparisons.

Onconova Therapeutics reported $7.7M in accounts payable as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $7.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Onconova Therapeutics, and consider following ONTX for alerts when major investors trade the stock.

Onconova Therapeutics is classified in the Healthcare sector. On accounts payable, it currently shows $7.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONTX with unrelated industries.